Tris Pharma
ApprovedA mission to uniquely solve some of the most intractable therapeutic challenges in ADHD, pain, addiction and central nervous system diseases.
Founded
2000
Focus
Drug DeliveryGeneric Drugs
About
A mission to uniquely solve some of the most intractable therapeutic challenges in ADHD, pain, addiction and central nervous system diseases.
Funding History
2Total raised: $150M
Debt$100MMidCap FinancialJun 15, 2018
Series A$50MUndisclosedJun 15, 2015
FDA Approved Drugs
1DEXTROMETHORPHAN POLISTIREXANDAMay 25, 2012
Company Info
TypePrivate
Founded2000
LocationMonmouth Junction, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile